Invited Speakers
Jianing Yue
Nationality
China
Current Position
Associated Chief Surgeon
Organization
Zhongshan Hospital Fudan University
Access SessionSaturday, Oct. 22, 2022 08:30-10:00 @Junior Ballroom

Topic: Value of stent-graft in dysfunctional AV fistulas and grafts: experience from China

Abstract

Fistuloplasty has been used for failing dialysis access for more than decade in China. In In certain types of lesions, primary patency is not satisfied. Bare metal stents has been proved do not improve PTA perfomance and are now recommended only for bailout. Covered stents show early promise, with some level 1 evidences that have been done to explore the role of covered stents in AVGs. In Zhongshan Hospital, we observed 52.6% and 72.4% primary patency at 12 monthes after covered stent implanted in AVG venous outflows and central venous obstructions respectively. In this presentation, we also reports our preliminary experience about the covered stent used in cephilic arch, central venous obstructions, AVG outflow and AVF anastomosis. However, many questions remain, including technical details, the long-term outcomes, and overall costs. Despite these issues, stent grafts are seems as promising, in some cases, have already surpassed fistuloplasty alone as the gold standard for treating dysfunctional dialysis accesses.

Session

Topic:

Abstract

Education

・Research Fellow, Saint Joseph’s Translational Research Institute, Atlanta, GA, 2009-2011
・PhD, Fudan University School of Medicine, Shanghai, China, 2008-2011
・Master Degree, Shanghai Jiaongtong University School of Medicine, Shanghai, China, 2004-2007
・Zhejiang University School of Medicine, Hangzhou, ZJ, China, 1998-2003

Research Experience

・Surgical management on Aortic Disease, Peripheral Arterial Disease and Hemodialysis Vascular Access
・Clinical and/or basic research on the aortic disease/peripheral arterial disease/arteriovenous access
・Cardiovascular Preclinical Studies/Novel peripheral vascular devices

Honors/Awards
  • Completed the first operation in China to establish the AVF with total autogenous superficial femoral vein transposition in lower extremity
  • Asian Society for Vascular Surgery Young Investigator Scholarship Champion of (DASy2019)
  • The first prize in the case competition at China Southern Endovascular Congress (SEC2014)
  • The grand prize in the presentation competition at China Endovascular Course (CEC2014)
  • Asian Society for Vascular Surgery Young Investigator Scholarship (ASVS2011) Third place in the Shanghai Young Surgeon Academic Competition (for the thesis of “analysis of risk factors and prognosis for the mesenteric ischemia”)
Selected Publications
  • Comparison between EVAR-selected and EVAR-only strategies for the management of ruptured abdominal aortic aneurysms: an 11-year experience at a Chinese tertiary hospital. Frontiers in Cardiovascular Medicine. 2022 Aug
  • Exosomal transfer of miR-185 is controlled by hnRNPA2B1 and impairs re-endothelialization after vascular injury. Front Cell Dev Biol. 2021 Apr 20;9:619444.
  • Chemical stabilization of the extracellular matrix attenuates growth of experimentally induced abdominal aorta aneurysms in a large animal model. JVS: Vascular Science
  • CircCBFB-mediated miR-28-5p facilitates abdominal aortic aneurysm via LYPD3 and GRIA4. Life Sci. 2020 Jul 15;253:117533 A Modified Murine Abdominal Aortic Aneurysm Rupture Model using Elastase Perfusion and Angiotensin II Infusion. Ann Vasc Surg. 2020 Aug;67:474-481.
  • MicroRNA-187 Reduces Acute Ischemic Renal Podocyte Injury via Targeting Acetylcholinesterase. J Surg Res. 2019 Dec;244:302-311.
  • MiR-210 inhibits apoptosis of vascular endothelial cells via JAK-STAT in arteriosclerosis obliterans. Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):319-326.
BACK

ASVS2022 Secretariat: 2022asvs@gmail.com

Copyright © The 23rd Congress of the Asian Society for Vascular Surgery All rights reserved.

Sponsored by National Science and Technology Council.